BURROWS SCOTT L (Chief Financial Officer) sold 11.3% of their position (12.50K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $892.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/2/2026ACC: 0001853327-26-000005
Officer· Chief Financial Officer
Since Mar 2026
-12.50K
Net shares
Net seller
$892.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.50K acquired · 25K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.50K
Price / share
$14.50
Trade value
$181.25K
% of position
12.8%
5/1/2026
97.99K→110.49K
Common Stock
Direct
Shares
−12.50K
Price / share
$71.37
Trade value
$892.13K
% of position
11.3%
5/1/2026
110.49K→97.99K
Total
Net shares
+0.00
Net value
-$710.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +12.50K | $14.50 | $181.25K | 12.8% | 97.99K | 110.49K |
| Common Stock Direct | 5/1/2026 | S · Sale | −12.50K | $71.37 | $892.13K | 11.3% | 110.49K | 97.99K |
| Total | +0.00 | -$710.88K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
14.50
Held after
382.36K
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 5/1/2026 | M · Option Exercise | −12.50K | 14.50 | — | 382.36K |